Exciting new research at University College London Hospital will test the drug Exenatide as a novel treatment for people with mild to moderate Parkinson's.
New research published in the journal Nature Medicine has shown for the first time that blocking the activity of LRRK2 - a gene known to be involved in Parkinson's – prevents nerve cell death in a mouse model of the condition.
There's a special 8-page supplement on Parkinson's in The Independent newspaper today, bringing Parkinson's and our work to the attention of around 190,000 Independent readers.
New research published today in the journal Nature Genetics suggests that subtle variations in genes that govern the immune system are involved in the development of Parkinson's.
A new way of studying nerve cells has been developed by Canadian researchers and is highlighted in the journal Biomedical Microdevices this month.
According to new research published in the journal Neurology, combining three simple tests may help identify people with Parkinson's who are more likely to fall.
The Summer 2010 issue of Progress, our Parkinson's research magazine, is now available to download. Gene therapy is under the spotlight, including the latest results from clinical trials.
New research reveals how a subtle variation in the LRRK2 gene causes the nerve cells affected in Parkinson's to die. This breakthrough sheds new light on the fundamental causes of Parkinson's.
GMTV presenter John Stapleton has lent his support to the World Parkinson Congress 2010 (WPC), which is coming to the UK for the first time later this year.
The European Health Commission has awarded €12million for one of the largest ever trials of cell transplantation for people with Parkinson's - co-ordinated by Parkinson's UK-funded researcher Roger Barker.
Parkinson's UK-funded researcher Dr Richard Wade-Martins is speaking today at the UK National Stem Cell Network conference about his research, which we hope will pave the way for new and better treatments for people with Parkinson's.
We're delighted that our Parkinson's Brain Donor Appeal has won a prestigious international award, taking awareness of the importance of brain donation to a worldwide audience.
New research published in the journal Nature shows that switching on specific nerve cells inside the brain can restore mobility in mice with Parkinson's-like movement problems.
Researchers funded by the Medical Research Council and Imperial College London say that they've overcome a major obstacle in the development of a cell transplant treatment system which could relieve the symptoms of Parkinson's.
We're calling for geriatricians, neurologists and Parkinson's nurses to help us improve services by taking part in our 2010 Parkinson's Audit. Registration for taking part closes on Monday 5 July 2010.
New research suggests that people with Parkinson's who are prone to freezing - suddenly being unable to move - may have difficulty gauging how much space they need for passing through small spaces like doorways.
We've awarded funding to Cardiff University for new research into how to stop the uncontrollable movements called dyskinesia, which are associated with some Parkinson's medication.
Dr Kieran Breen, our Director of Research and Development, commented in the Daily Mail this week on a new study linking loss of sense of smell with early signs of Parkinson's.
Research published in the Journal of Alzheimer's Disease found that people who regularly drink 2 to 3 cups of coffee a day cut their risk of developing Parkinson's by a quarter.
Our Brain Donor Appeal, which ran last year, has been shortlisted for the CIPR (Chartered Institute of Public Relations) Excellence Awards 2010.